This prestigious recognition reflects Lindus’ ongoing commitment to developing adaptive, innovative technology that fixes the broken Contract Research Organization (CRO) model through its all-in-one solution.
November 13, 2025
2
mins read
Lindus Health Named Rising Star in the 2025 Deloitte Technology Fast 50
New Pharmanovia Study Results Reveal Chloral Hydrate Noticeably Improves Severe Insomnia Within Two Weeks
10/1/24
3
mins
Pharmanovia's chloral hydrate elicited improvements in patients with severe insomnia. Learn more about our study together here.
Lindus Health Launches “All-in-One Ophthalmology CRO” Tailored to Clinical Trials in Ophthalmology
9/4/24
Introducing the latest CRO offering for the ophthalmology market segment.
Lindus Health Announces the Completion of Two Clinical Trials for Woebot Health’s Digital Application for Depression and Anxiety Symptoms
8/22/24
Sharing recent developments from our recent trials with Woebot Health.
Lindus Health Unveils “All-in-One Dermatology CRO” Offering for Dermatology Clinical Trials
8/6/24
Introducing our "All-in-One Dermatology CRO" bespoke to dermatology clinical trials.
PILA PHARMA INKS AGREEMENT WITH LINDUS HEALTH ABOUT NEXT CLINICAL TRIAL WITH SAFETY AND OBESITY READOUTS
7/24/24
4
Announcing our Phase 2a clinical trial with PILA PHARMA to assess the tolerability, safety, and efficacy of XEN-D0501 in patients with type II diabetes and obesity.
Lindus Health and Aktiia to launch observational clinical trial for Aktiia’s Optical Blood Pressure Monitoring Device
7/9/24
We're pleased to announce the launch of our 7,500-participant trial with Aktiia!
